Astrazeneca (AZN) EBITDA (2009 - 2026)
Astrazeneca's EBITDA came in at $5.09 billion for Q2 2026, up 4.0% from $4.9 billion a year earlier but down 9.2% from the prior quarter.
Powered by 
Analysis
Astrazeneca (AZN) EBITDA (2009 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Astrazeneca reported EBITDA of $20.33 billion, up 12.0% year-over-year; for FY2025, it was $19.48 billion, up 16.7% from FY2024.
- EBITDA has increased in each of the last four years, with a five-year compound annual growth rate of 18.6% (FY2020 to FY2025).
- Going back by year, EBITDA was $16.69 billion in FY2024 (+22.9%), $13.58 billion in FY2023 (+47.0%), $9.24 billion in FY2022 (+21.8%) and $7.59 billion in FY2021 (-8.7%).
- The five-year range for quarterly EBITDA is $1.11 billion (Q3 2021) to $5.61 billion (Q1 2026).
- Year-over-year, EBITDA has increased for six consecutive quarters, with growth averaging 14.3% over the last six quarters.
- The fastest year-over-year change in EBITDA over five years came in Q2 2023 (growth of 96.8%), and the weakest in Q4 2021 (a decline of 50.5%).
- Business Quant data shows AZN's EBITDA at $5.61 billion (Q1 2026), $4.49 billion (Q4 2025) and $5.13 billion (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 9.10 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 8.33 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 999.00 Mn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 5.09 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 4.63 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | -9.70 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 5.89 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 1.30 Bn |
| 10 | Bristol Myers Squibb | 127.55 Bn | 78.82 Bn | 9.25 Bn | 954.00 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 5.09 Bn |
| Mar 31, 2026 | 5.61 Bn |
| Dec 31, 2025 | 4.49 Bn |
| Sep 30, 2025 | 5.13 Bn |
| Jun 30, 2025 | 4.90 Bn |
| Mar 31, 2025 | 4.96 Bn |
| Dec 31, 2024 | 4.37 Bn |
| Sep 30, 2024 | 3.92 Bn |
| Jun 30, 2024 | 4.03 Bn |
| Mar 31, 2024 | 4.37 Bn |
| Jun 30, 2023 | 3.73 Bn |
| Mar 31, 2023 | 4.05 Bn |
| Jun 30, 2022 | 1.90 Bn |
| Mar 31, 2022 | 2.19 Bn |
| Dec 31, 2021 | 1.90 Bn |
| Sep 30, 2021 | 1.11 Bn |
| Jun 30, 2021 | 1.88 Bn |
| Mar 31, 2021 | 2.69 Bn |
| Dec 31, 2020 | 3.84 Bn |
| Sep 30, 2020 | 1.97 Bn |
API Access
Astrazeneca EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda&ticker=AZN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda", "ticker": "AZN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda&ticker=AZN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();